← SynDRA
Ginsenoside Re
SynDRA canonical compound SYN2007941 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MAPK8 | NFKB1 | NFKB2 | REL | RELA | RELB |
|---|
| Mechanism of action | anti-inflammatory agent |
|---|
Cross-references
Synonyms
- Ginsenoside B2
- Panaxoside RE
- Sanchinoside Re
- NSC-308877
- CHEBI:77148
- RefChem:37695
- DTXCID201747118
- Chikusetsusaponin IVc
- MFCD00133369
- Ginsenoside Re (Standard)
- GinsenosideRe
- UNII-46F3R0BL3I
- panaxsaponin Re
- EINECS 257-814-6
- Ginsenoside B2; Panaxoside Re; Sanchinoside Re
- (20S)-ginsenoside Re
- Ginsenoside B2(Standard)
- SCHEMBL669738
- HY-N0044R
- WLZ4722
- GLXC-13358
- EX-A6794
- HY-N0044
- MSK40093
- BDBM50378779
- s3811
- AKOS025310861
- CCG-270589
- CS-3838
- EBC-618394
- OG09285
- NCGC00483098-01
- AC-33946
- SY076028
- G0551
- G3457
- C08944
- NSC 308877
- NSC308877
Look up Ginsenoside Re in the interactive SynDRA portal →